Invitae Patent Win Stands, But Qiagen Escapes Injunction for Now

Invitae Corp.’s ArcherDX defeated Qiagen NV’s bid to overturn a jury’s $4.6 million patent-infringement verdict on genetic-sequencing products and won more than $1.2 million in supplemental damages, but a federal judge denied ArcherDX’s injunction request and granted an ongoing royalty at a rate less than it requested.

Citing “substantial evidence” supporting the jury’s infringement findings, Judge Maryellen Noreika denied Qiagen Sciences LLC‘s motion for noninfringement judgments and rejected its request to cancel the two patents, according to an opinion issued Sept. 30 in the US District Court for the District of Delaware.

In August 2021, federal jurors in ...